retatrutide when will it be available 🎙️ NEW EPISODE: Retatrutide—The Triple Agonist *Not licensed* this replace the current GLP-1 in the market., This triple receptor agonist (GIP/GLP-1/glucagon) is showing unprecedented results in ESC 2024: Retatrutide improves lipid

The limitation is duration

Body composition changes with GLP-1 receptor agonist treatment in adults with obesity: a systematic review and meta-analysis

Frequent follow-up appointments and communication with healthcare teams facilitated patients in reporting these symptoms and obtaining management advice

Constipation: This is a major consideration for IBS-C patients on GLP-1, but even those with IBS-M or IBS-D should be aware of it

GLP-1 improves insulin sensitivity, thereby reducing systemic inflammatory stress

To solve the problem of rapid inactivation of incretins, scientists began to search for similar compounds in the animal world